Medpage Today on MSN1d
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Medscape4d
The Role of Kidney in Glucose Homeostasis — SGLT2 Inhibitors, a New Approach in Diabetes Treatment
[1] The purpose of this review paper is to analyze the role of the kidney in glucose homeostasis, emphasizing in SGLT2 inhibition ... Urinary glucose excretion (g/24 h):/DP100 mg: 69.9/DP20 ...
EurekAlert!2d
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
The Lancet1d
Sodium–glucose co-transporter inhibitors—who would have guessed?
Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
Science Daily2d
Kidney Disease News
Feb. 11, 2025 — Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map ...
Nature2d
Nephrology articles from across Nature Portfolio
Nephrology is specialty of medicine concerned with kidney physiology, kidney disease, the treatment of kidney problems and renal replacement therapy. Systemic conditions that affect the kidneys (e ...
GP magazine4d
ACE inhibitors and renal artery stenosis
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Johns Hopkins Medicine2d
Kidney Scan
What is a kidney scan? A kidney scan is an imaging test that looks at your kidneys. Your health care provider can also see how well blood is flowing in your kidneys. A kidney scan is also called a ...